Anti-microbial/Anti-fungal Tests Market
Discover with FMI How Anti-microbial/Anti-fungal Tests are Gaining Traction Amond Patients with Fungal Infections!
Anti-microbial/Anti-fungal Tests Market by Tests, Infection, End User & Region - Forecast 2022 - 2032
Anti-microbial/Anti-fungal Tests Market Outlook (2022-2032)
[268 Pages Report] The global anti-microbial/anti-fungal tests market is expected to reach US$ 2.5 Bn by the end of 2022. Growth in the market is predicted to expand at a CAGR rate of 5.7% and surpass ~US$ 4.5 Bn by 2032. Based on tests type, the molecular-based tests led the market with a share of nearly 53.5% in 2021.
|
Attributes |
Key Insights |
|
Anti-microbial/Anti-fungal Tests Market Value 2021 |
US$ 2.4 Bn |
|
Estimated Market Size 2022 |
US$ 2.5 Bn |
|
Projected Market Value 2032 |
US$ 4.5 Bn |
|
CAGR 2022-2032 |
5.7% |
|
Market Share of Top 5 Countries |
55.0% |
Microorganism screening to create novel antibiotics has been successfully pursued for numerous years by the researcher. Fungus and bacteria often generate antibiotics. Bacteria are consumed in a variety of fields, including agriculture. In the pharmaceutical and veterinary industries, an antimicrobial is a substance that kills or inhibits bacterial growth.
Antibiotics are employed against antifungals, and bacteria are utilized against fungi in these cases. Antimicrobial chemotherapeutic uses antimicrobial drugs to combat infection, and antimicrobial prophylaxis uses antimicrobial medicines to prevent infection. Antimicrobial susceptibility tests can help physicians choose the best medicine and dosage for difficult-to-treat infections.
Let us know your requirement to get
100% FREE customization
Sales Analysis of Anti-microbial/Anti-fungal Tests Market from 2012 to 2021 Vs Demand Outlook for 2022 to 2032
As per Future Market Insights (FMI), the anti-microbial/anti-fungal tests market was approximately 15.4% of the overall ~US$ 15.6 Bn global rapid testing kits market in 2021. Overall sales in the anti-microbial/anti-fungal tests market surged at a CAGR of 5.6% from 2012 to 2021.
Growth in the market is primarily attributed to the increased prevalence of infectious diseases across the globe. Furthermore, rising rates of surgical site infections and other related issues are propelling the sales in the antimicrobial antifungal test market. Further, advancements in biotechnology and in diagnostic procedures is facilitating the growth in the market.
As a number of pathogenic bacteria develop antibiotic resistance and novel forms of resistance emerge, healthcare professionals are focusing on antimicrobial susceptibility testing (AST). Minimum inhibitory concentrations (MICs) are provided by a rapid multiplexed AST platform at a reasonable cost, allowing for the rapid determination of effective targeted therapy. This is resulting in shorter hospital stays, fewer laboratory tests, and lower morbidity and mortality, as well as associated healthcare costs.
Furthermore, the market witnessed prolific growth as the use of antibiotic and antifungal skyrocketed. Further, nosocomial bacterial superinfections are more common than community-acquired coinfections. This is particularly among ICU patients and those taking immunosuppressive therapy. On the back of these factors, the global anti-microbial/anti-fungal tests market is expected to grow at a CAGR of 5.7% during the forecast period.
What are the Key Opportunities in the Anti-microbial/Anti-fungal Tests Kit Market?
- Favorable Government Initiatives and Awareness Programs to Fuel the Growth
Favorable government initiatives and development of healthcare infrastructure across the globe is the key factor propelling the sales in the global anti-microbial/anti-fungal tests kit market. Advancements in point-of-care (POC) detection methods that enable decentralised, quick, sensitive, low-cost COVID-19 infection diagnostics are spuuring the growth in the market.
Furthermore, rising awareness by government bodies has positively impacted manufacturers and healthcare service providers. For instance, WAAW was formerly known as World Antibiotic Awareness Week, which is now changed to World Antimicrobial Awareness Week in 2020. This reflects WAAW's expanded scope, which now includes all antimicrobials such as antifungals, antibiotics, antiparasitics, and antivirals.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat are the Factors Restraining Demand for Anti-microbial/Anti-fungal Tests?
The lack of an innovation culture and stringent regulatory approvals might hamper the demand in the market. In general, healthcare providers and medical workers are risk-averse and resistant to policy reforms. In the realm of in-vitro diagnostics, there have been numerous instances where physicians have been highly reluctant to advance. Furthermore, the administration and organization of diagnostic services may further restrict the market in the forecast period's coming years.
Further, the complexity in interpreting the paradoxical growth phenomenon seen with echinocandins and yeasts (which differs from the trailing effect) and uncertainty for caspofungin testing is due to the molecule's lack of stability in culture media. These factors cumulatively might negatively affect the growth in the anti-microbial/anti-fungal tests market.
Country-wise Insights
How will the Sales in the U.S. Anti-microbial/Anti-fungal Tests Market Increase?
Growing Preference for Diagnostic Tests to Boost the Sales
The U.S. dominated the North America anti-micorbial/anti-fungal tests market with a total share of about 89.4% in 2021. Growth in the market is primarily underpinned by growing preference for diagnostic tests recommended by physicians before any type of treatment. Furthermore, widespread awareness of the adverse effects of particular medications, and patients frequently prefer to be fully diagnosed before seeking treatment.
Will China Retain its Dominance in Anti-microbial/Anti-fungal Tests Market?
Rising Prevalence of NIC and Diabetes Mellitus to Facilitate the Growth in China
China held approximately 7.5% share in the global anti-microbial/anti-fungal tests market in 2021, as per FMI. Sales in the market are projected to display growth at a CAGR of 7.1% during the forecast period.
Due to the increased number of immunocompromised individuals, invasive fungal infections (IFIs), especially those caused by uncommon yeasts, are becoming more common. Invasive candidiasis is the key concern with significant morbidity and mortality.
It affects patients of all ages, including those with malignancies, non-immunocompromised (NIC) and HIV-negative immunocompromised (IC) patients, individuals among the severely ill, typically hospitalised to an intensive care unit (ICU), or diagnosed with diabetes mellitus or uncontrolled hyperglycaemia needing invasive mechanical ventilation.
How Big is the Opportunity in Germany Anti-microbial/Anti-fungal Tests Market?
Germany Anti-microbial/Anti-fungal Tests Market to Gain from Rising Incidence of Fungal Infection
Germany is set to exhibit a CAGR growth of nearly 7.1% in the Europe anti-microbial/anti-fungal tests market during the forecast period. Candida glabrata is the second most common fungal infection in Germany, causing candidaemia and invasive candidiasis.
This yeast is known for its quick acquisition of antifungal medication resistance. Furthermore, with the increasing prevalence of chronic and infectious diseases, the ageing population will demand the anti-microbial/anti-fungal tests market.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Category-wise Insights
Which Anti-microbial/Anti-fungal Tests Type is Driving the Growth?
Molecular Based Tests to Gain Immense Traction through 2022 & Beyond
Molecular-based tests are expected to lead the market, registering growth at a CAGR of 5.3% during the forecast period. The segment is expecetd to account for a share of more than 50.0% in the global anti-microbial/anti-fungal tests market. Owing to their factors of increasing susceptibility, minimization of false positive results, better turnaround time and possesses wide applications.
Based on infection, the antimicrobial resistance held revenue share of 48% in 2021 and is expected to display gradual growth over the forecast period. Antimicrobial resistance (AMR) emerges when fungi, viruses, bacteria, and parasites evolve over a period. Therefore it shows no longer responds to the antibiotics treatment, making infections more challenging to treat and increasing the risk of disease spread, major illness, and death. This is expected to fuel revenue growth over the forecast period.
Which is the Leading End User in Anti-microbial/Anti-fungal Tests Market?
Nearly 2 out of 5 Sales to be Contributed by Hospitals
As per FMI, hospitals held the market with the highest share value of 36.9% and are expected to maintain the lead over the upcoming decade. Increasing hospital-acquired infections and increasing inpatient admissions are propelling sales of the overall anti-microbial/anti-fungal tests market.
Competitive Landscape
With several competitors in the anti-microbial/anti-fungal tests market, the overall market is fragmented. To meet consumer demand and expand their customer base, these companies are implementing methods such as mergers and acquisitions, partnerships and collaborations, and new product launches.
- In July 2022, Roche announced that Elecsys HCV Duo immunoassay is now available in countries that accept the CE Mark. Elecsys HCV Duo is the only immunoassay on the market that can determine hepatitis C virus (HCV) antigen and antibody status from a single human plasma or serum sample.
- In June 2022, Meridian Bioscience, Inc., a global leader in diagnostic testing solutions and life science raw materials, introduced two new sample-specific master mixes, Lyo-Ready Direct DNA qPCR Stool Mix and Lyo-Ready Direct RNA/DNA qPCR Stool Mix. These novel master mixes increase the molecular detection of DNA and RNA from crude faecal materials while allowing diagnostic procedures to be room temperature stabilised.
Report Scope as per Anti-microbial/Anti-fungal Tests Industry Analysis
|
Attribute |
Details |
|
Estimated Market Size 2022 |
US$ 2.5 Bn |
|
Projected Market Value 2032 |
US$ 4.5 Bn |
|
CAGR 2022-2032 |
5.7% |
|
Forecast Period |
2012-2021 |
|
Historical Data Available for |
2022-2032 |
|
Market Analysis |
US$ Mn for Value |
|
Key Regions Covered |
North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa |
|
Key Countries Covered |
U.S., Canada, Brazil, Mexico, Argentina, U.K., Germany, Italy, Russia, Spain, France, BENELUX, Nordic Countries, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC, South Africa and North Africa |
|
Key Market Segments Covered |
Tests, Infection, End User, and Region |
|
Key Companies Profiled |
|
Key Market Segments Covered in Anti-microbial/Anti-fungal Tests Industry Research
By Tests Type:
- Molecular Based Tests
- PCR Test
- DNA Microarray
- Phenotypic Resistance Tests
- Complex Test Panels
- Mass Spectrometry
- Rapid Diagnostic Tests
- E-Test Antibiotic/Antifungal Strips
- Biosensor Platforms
By Infection Type:
- Antimicrobial Resistance
- Methicillin-Resistant Staphylococcus Aureus
- Vancomycin-Resistant Enterococcus
- Multi-Drug-Resistant Mycobacterium tuberculosis
- Carbapenem-Resistant Enterobacteriaceae gut bacteria
- Microbial Infection
- Antifungal Resistance
- Candida infections
- Aspergillus infection
- Fusariosis
- Others
- Fungal Infection
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Clinics
- Community Health Centers
- Reference Laboratories
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
Frequently Asked Questions
The global anti-microbial/anti-fungal tests market is worth US$ 2.4 Bn in 2021 and is set to expand 1.7X over the next ten years.
The anti-microbial/anti-fungal tests market is expected to reach US$ 4.5 Bn by the end of 2032, with sales revenue expected to register a 5.7% CAGR.
The growing geriatric population and innovative product development, increasing prevalence of antimicrobial resistance cases are some of the key trends in this market.
U.S., India, China, Germany, and Japan are expected to drive demand for the anti-microbial/anti-fungal tests industry.
North America is one of the key markets for anti-microbial/anti-fungal tests, with the U.S. accounting for about 89.4% of the North American anti-microbial/anti-fungal tests market in the year 2021.
Demand for anti-microbial/anti-fungal tests in Europe is expected to register a growth of 5.0% CAGR over the next ten years.
Demand for anti-microbial/anti-fungal tests in MEA is expected to register a growth of 4.5% over the next ten years.
China and the U.S., Germany are the key producers of anti-microbial/anti-fungal tests.
Abbott Laboratories, bioMérieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, Danaher Corporation, Erba Mannheim, F. Hoffmann-La Roche AG, Luminex Corporation, Meridian Bioscience Inc., Norgen Biotek Corp., Omega Diagnostics Group Plc., Qiagen N.V., Quidel Corporation, and Thermo Fisher Scientific Inc., are some of the key players in the anti-microbial/anti-fungal tests industry.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Epidemiology of Key Indication, By Region
4.2. Key Promotional Strategies
4.3. Patient Journey
4.4. Regulatory Scenario
4.5. Reimbursement Landscape
4.6. PESTEL analysis
4.7. Porter’s analysis
4.8. Value Chain
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare GDP Growth Overview
5.2. Forecast Factors - Relevance & Impact
5.2.1. Rising Prevalence of infectious diseases.
5.2.2. Increasing Awareness and Adoption.
5.2.3. Increase in rapid diagnostics tests.
5.2.4. Increasing prevalence of antimicrobial resistance patients.
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
5.4. Global Supply Demand Analysis
6. COVID-19 Crisis – Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.2. 2021 Market Scenario
6.2.1. By Tests Type
6.2.2. By Infection Type
6.2.3. By End User
6.2.4. By Region
7. Global Anti-microbial/Anti-fungal Tests Market Demand (in Value or Size in US$ Mn) Analysis 2012-2021 and Forecast, 2022–2032
7.1. Historical Market Value (US$ Mn) Analysis, 2012-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Anti-microbial/Anti-fungal Tests Market Analysis 2012-2021 and Forecast 2022–2032, By Tests Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Tests Type, 2012-2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Tests Type, 2022–2032
8.3.1. Molecular Based Tests
8.3.1.1. PCR Test
8.3.1.2. DNA Microarray
8.3.2. Phenotypic Resistance Tests
8.3.3. Complex Test Panels
8.3.4. Mass Spectrometry
8.3.5. Rapid Diagnostic Tests
8.3.5.1. E-Test Antibiotic/Antifungal Strips
8.3.5.2. Biosensor Platforms
8.4. Market Attractiveness Analysis By Tests Type
9. Global Anti-microbial/Anti-fungal Tests Market Analysis 2012-2021 and Forecast 2022–2032, By Infection Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis, By Infection Type, 2012-2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Infection Type, 2022–2032
9.3.1. Antimicrobial Resistance
9.3.1.1. Methicillin-Resistant Staphylococcus Aureus
9.3.1.2. Vancomycin-Resistant Enterococcus
9.3.1.3. Multi-Drug-Resistant Mycobacterium tuberculosis
9.3.1.4. Carbapenem-Resistant Enterobacteriaceae gut bacteria
9.3.2. Microbial Infection
9.3.3. Antifungal Resistance
9.3.3.1. Candida infections
9.3.3.2. Aspergillus infection
9.3.3.3. Fusariosis
9.3.3.4. Others
9.3.4. Fungal Infection
9.4. Market Attractiveness Analysis By Infection Type
10. Global Anti-microbial/Anti-fungal Tests Market Analysis 2012-2021 and Forecast 2022–2032, By End User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis, By End User, 2012-2021
10.3. Current and Future Market Size (US$ Mn) Analysis Forecast By End User, 2022–2032
10.3.1. Hospitals
10.3.2. Ambulatory Surgical Centers
10.3.3. Clinics
10.3.4. Community Health Centers
10.3.5. Reference Laboratories
10.4. Market Attractiveness Analysis By End User
11. Global Anti-microbial/Anti-fungal Tests Market Analysis 2012-2021 and Forecast 2022–2032, by Region
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2012-2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022–2032
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region
12. North America Anti-microbial/Anti-fungal Tests Market Analysis 2012-2021 and Forecast 2022–2032
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2012-2021
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Tests Type
12.3.3. By Infection Type
12.3.4. By End User
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Tests Type
12.4.3. By Infection Type
12.4.4. By End User
12.5. Market Trends
12.6. Key Market Participants - Intensity Mapping
12.7. Drivers and Restraints - Impact Analysis
12.8. Country Level Analysis & Forecast
12.8.1. U.S. Anti-microbial/Anti-fungal Tests Market Analysis
12.8.1.1. Introduction
12.8.1.2. Market Analysis and Forecast by Market Taxonomy
12.8.1.2.1. By Tests Type
12.8.1.2.2. By Infection Type
12.8.1.2.3. By End User
12.8.2. Canada Anti-microbial/Anti-fungal Tests Market Analysis
12.8.2.1. Introduction
12.8.2.2. Market Analysis and Forecast by Market Taxonomy
12.8.2.2.1. By Tests Type
12.8.2.2.2. By Infection Type
12.8.2.2.3. By End User
13. Latin America Anti-microbial/Anti-fungal Tests Market Analysis 2012-2021 and Forecast 2022–2032
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2012-2021
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032
13.3.1. By Country
13.3.1.1. Mexico
13.3.1.2. Brazil
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.2. By Tests Type
13.3.3. By Infection Type
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Tests Type
13.4.3. By Infection Type
13.4.4. By End User
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country Level Analysis & Forecast
13.8.1. Mexico Anti-microbial/Anti-fungal Tests Market Analysis
13.8.1.1. Introduction
13.8.1.2. Market Analysis and Forecast by Market Taxonomy
13.8.1.2.1. By Tests Type
13.8.1.2.2. By Infection Type
13.8.1.2.3. By End User
13.8.2. Brazil Anti-microbial/Anti-fungal Tests Market Analysis
13.8.2.1. Introduction
13.8.2.2. Market Analysis and Forecast by Market Taxonomy
13.8.2.2.1. By Tests Type
13.8.2.2.2. By Infection Type
13.8.2.2.3. By End User
13.8.3. Argentina Anti-microbial/Anti-fungal Tests Market Analysis
13.8.3.1. Introduction
13.8.3.2. Market Analysis and Forecast by Market Taxonomy
13.8.3.2.1. By Tests Type
13.8.3.2.2. By Infection Type
13.8.3.2.3. By End User
14. Europe Anti-microbial/Anti-fungal Tests Market Analysis 2012-2021 and Forecast 2022–2032
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2012-2021
14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. U.K.
14.3.1.5. Spain
14.3.1.6. BENELUX
14.3.1.7. Russia
14.3.1.8. Rest of Europe
14.3.2. By Tests Type
14.3.3. By Infection Type
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Tests Type
14.4.3. By Infection Type
14.4.4. By End User
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis & Forecast
14.8.1. Germany Anti-microbial/Anti-fungal Tests Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Tests Type
14.8.1.2.2. By Infection Type
14.8.1.2.3. By End User
14.8.2. Italy Anti-microbial/Anti-fungal Tests Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Tests Type
14.8.2.2.2. By Infection Type
14.8.2.2.3. By End User
14.8.3. France Anti-microbial/Anti-fungal Tests Market Analysis
14.8.3.1. Introduction
14.8.3.2. Market Analysis and Forecast by Market Taxonomy
14.8.3.2.1. By Tests Type
14.8.3.2.2. By Infection Type
14.8.3.2.3. By End User
14.8.4. U.K. Anti-microbial/Anti-fungal Tests Market Analysis
14.8.4.1. Introduction
14.8.4.2. Market Analysis and Forecast by Market Taxonomy
14.8.4.2.1. By Tests Type
14.8.4.2.2. By Infection Type
14.8.4.2.3. By End User
14.8.5. Spain Anti-microbial/Anti-fungal Tests Market Analysis
14.8.5.1. Introduction
14.8.5.2. Market Analysis and Forecast by Market Taxonomy
14.8.5.2.1. By Tests Type
14.8.5.2.2. By Infection Type
14.8.5.2.3. By End User
14.8.6. BENELUX Anti-microbial/Anti-fungal Tests Market Analysis
14.8.6.1. Introduction
14.8.6.2. Market Analysis and Forecast by Market Taxonomy
14.8.6.2.1. By Tests Type
14.8.6.2.2. By Infection Type
14.8.6.2.3. By End User
14.8.7. Russia Anti-microbial/Anti-fungal Tests Market Analysis
14.8.7.1. Introduction
14.8.7.2. Market Analysis and Forecast by Market Taxonomy
14.8.7.2.1. By Tests Type
14.8.7.2.2. By Infection Type
14.8.7.2.3. By End User
15. South Asia Anti-microbial/Anti-fungal Tests Market Analysis 2012-2021 and Forecast 2022–2032
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2012-2021
15.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy, 2022–2032
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Indonesia
15.3.1.3. Malaysia
15.3.1.4. Thailand
15.3.1.5. Rest of South Asia
15.3.2. By Tests Type
15.3.3. By Infection Type
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Tests Type
15.4.3. By Infection Type
15.4.4. By End User
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis & Forecast
15.8.1. India Anti-microbial/Anti-fungal Tests Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Tests Type
15.8.1.2.2. By Infection Type
15.8.1.2.3. By End User
15.8.2. Indonesia Anti-microbial/Anti-fungal Tests Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Tests Type
15.8.2.2.2. By Infection Type
15.8.2.2.3. By End User
15.8.3. Malaysia Anti-microbial/Anti-fungal Tests Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Tests Type
15.8.3.2.2. By Infection Type
15.8.3.2.3. By End User
15.8.4. Thailand Anti-microbial/Anti-fungal Tests Market Analysis
15.8.4.1. Introduction
15.8.4.2. Market Analysis and Forecast by Market Taxonomy
15.8.4.2.1. By Tests Type
15.8.4.2.2. By Infection Type
15.8.4.2.3. By End User
16. East Asia Anti-microbial/Anti-fungal Tests Market Analysis 2012-2021 and Forecast 2022–2032
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2012-2021
16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Tests Type
16.3.3. By Infection Type
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Tests Type
16.4.3. By Infection Type
16.4.4. By End User
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis & Forecast
16.8.1. China Anti-microbial/Anti-fungal Tests Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Tests Type
16.8.1.2.2. By Infection Type
16.8.1.2.3. By End User
16.8.2. Japan Anti-microbial/Anti-fungal Tests Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Tests Type
16.8.2.2.2. By Infection Type
16.8.2.2.3. By End User
16.8.3. South Korea Anti-microbial/Anti-fungal Tests Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast by Market Taxonomy
16.8.3.2.1. By Tests Type
16.8.3.2.2. By Infection Type
16.8.3.3. By End User
17. Oceania Anti-microbial/Anti-fungal Tests Market 2017-2021 and Forecast 2022-2032
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2012-2021
17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Tests Type
17.3.3. By Infection Type
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Tests Type
17.4.3. By Infection Type
17.4.4. By End User
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country Level Analysis & Forecast
17.8.1. Australia Anti-microbial/Anti-fungal Tests Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Tests Type
17.8.1.2.2. By Infection Type
17.8.1.2.3. By End User
17.8.2. New Zealand Anti-microbial/Anti-fungal Tests Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Tests Type
17.8.2.2.2. By Infection Type
17.8.2.2.3. By End User
18. Middle East and Africa (MEA) Anti-microbial/Anti-fungal Tests Market Analysis 2012-2021 and Forecast 2022–2032
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2012-2021
18.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy, 2022–2032
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Turkey
18.3.1.3. South Africa
18.3.1.4. North Africa
18.3.2. By Tests Type
18.3.3. By Infection Type
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Tests Type
18.4.3. By Infection Type
18.4.4. By End User
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country Level Analysis & Forecast
18.8.1. GCC Countries Anti-microbial/Anti-fungal Tests Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast by Market Taxonomy
18.8.1.2.1. By Tests Type
18.8.1.2.2. By Infection Type
18.8.1.2.3. By End User
18.8.2. Turkey Anti-microbial/Anti-fungal Tests Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast by Market Taxonomy
18.8.2.2.1. By Tests Type
18.8.2.2.2. By Infection Type
18.8.2.2.3. By End User
18.8.3. South Africa Anti-microbial/Anti-fungal Tests Market Analysis
18.8.3.1. Introduction
18.8.3.2. Market Analysis and Forecast by Market Taxonomy
18.8.3.2.1. By Tests Type
18.8.3.2.2. By Infection Type
18.8.3.2.3. By End User
18.8.4. North Africa Anti-microbial/Anti-fungal Tests Market Analysis
18.8.4.1. Introduction
18.8.4.2. Market Analysis and Forecast by Market Taxonomy
18.8.4.2.1. By Tests Type
18.8.4.2.2. By Infection Type
18.8.4.2.3. By End User
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Share Analysis of Top Players
19.3. Market Presence Analysis
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. Abbott Laboratories
20.3.1.1. Overview
20.3.1.2. Product Portfolio
20.3.1.3. Fey Financials
20.3.1.4. Sales Footprint
20.3.1.5. Strategy Overview
20.3.2. bioMérieux SA,
20.3.2.1. Overview
20.3.2.2. Product Portfolio
20.3.2.3. Fey Financials
20.3.2.4. Sales Footprint
20.3.2.5. Strategy Overview
20.3.3. Bio-Rad Laboratories Inc.,
20.3.3.1. Overview
20.3.3.2. Product Portfolio
20.3.3.3. Fey Financials
20.3.3.4. Sales Footprint
20.3.3.5. Strategy Overview
20.3.4. Bruker Corporation,
20.3.4.1. Overview
20.3.4.2. Product Portfolio
20.3.4.3. Fey Financials
20.3.4.4. Sales Footprint
20.3.4.5. Strategy Overview
20.3.5. Danaher Corporation,
20.3.5.1. Overview
20.3.5.2. Product Portfolio
20.3.5.3. Fey Financials
20.3.5.4. Sales Footprint
20.3.5.5. Strategy Overview
20.3.6. Erba Mannheim,
20.3.6.1. Overview
20.3.6.2. Product Portfolio
20.3.6.3. Fey Financials
20.3.6.4. Sales Footprint
20.3.6.5. Strategy Overview
20.3.7. F. Hoffmann-La Roche AG,
20.3.7.1. Overview
20.3.7.2. Product Portfolio
20.3.7.3. Fey Financials
20.3.7.4. Sales Footprint
20.3.7.5. Strategy Overview
20.3.8. Luminex Corporation,
20.3.8.1. Overview
20.3.8.2. Product Portfolio
20.3.8.3. Fey Financials
20.3.8.4. Sales Footprint
20.3.8.5. Strategy Overview
20.3.9. Meridian Bioscience Inc.,
20.3.9.1. Overview
20.3.9.2. Product Portfolio
20.3.9.3. Fey Financials
20.3.9.4. Sales Footprint
20.3.9.5. Strategy Overview
20.3.10. Norgen Biotek Corp.,
20.3.10.1. Overview
20.3.10.2. Product Portfolio
20.3.10.3. Fey Financials
20.3.10.4. Sales Footprint
20.3.10.5. Strategy Overview
20.3.11. Omega Diagnostics Group Plc.,
20.3.11.1. Overview
20.3.11.2. Product Portfolio
20.3.11.3. Fey Financials
20.3.11.4. Sales Footprint
20.3.11.5. Strategy Overview
20.3.12. Qiagen N.V.,
20.3.12.1. Overview
20.3.12.2. Product Portfolio
20.3.12.3. Fey Financials
20.3.12.4. Sales Footprint
20.3.12.5. Strategy Overview
20.3.13. Quidel Corporation,
20.3.13.1. Overview
20.3.13.2. Product Portfolio
20.3.13.3. Fey Financials
20.3.13.4. Sales Footprint
20.3.13.5. Strategy Overview
20.3.14. Thermo Fisher Scientific Inc.
20.3.14.1. Overview
20.3.14.2. Product Portfolio
20.3.14.3. Fey Financials
20.3.14.4. Sales Footprint
20.3.14.5. Strategy Overview
21. Assumptions and Acronyms Used
22. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Anti-microbial / Anti-fungal Tests Market Analysis 2012–2021 and Forecast 2022–2032, by Test
Table 02: Global Anti-microbial / Anti-fungal Tests Market Analysis 2012–2021 and Forecast 2022–2032by Infection
Table 03: Global Anti-microbial / Anti-fungal Tests Market Analysis 2012–2021 and Forecast 2022–2032, by End User
Table 04: Global Anti-microbial / Anti-fungal Tests Market Analysis 2012–2021 and Forecast 2022–2032, by Region
Table 05: North America Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country
Table 06: North America Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Test
Table 07: North America Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Infection
Table 08: North America Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by End User
Table 09: Latin America Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country
Table 10: Latin America Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Test
Table 11: Latin America Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Infection
Table 12: Latin America Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by End User
Table 13: Europe Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country
Table 14: Europe Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Test
Table 15: Europe Anti-microbial / Anti-fungal Tests Market Analysis 2012–2021 and Forecast 2022–2032by Infection
Table 16: Europe Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by End User
Table 17: East Asia Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country
Table 18: East Asia Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Test
Table 19: East Asia Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Infection
Table 20: East Asia Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by End User
Table 21: South Asia Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country
Table 22: South Asia Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Test
Table 23: South Asia Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Infection
Table 24: South Asia Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by End User
Table 25: Oceania Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country
Table 26: Oceania Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Test
Table 27: Oceania Anti-microbial / Anti-fungal Tests Market Analysis 2012–2021 and Forecast 2022–2032by Infection
Table 28: Oceania Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by End User
Table 29: Middle East & Africa Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country
Table 30: Middle East & Africa Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Test
Table 31: Middle East & Africa Anti-microbial / Anti-fungal Tests Market Analysis 2012–2021 and Forecast 2022–2032by Infection
Table 32: Middle East & Africa Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by End User
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis, 2012–2021
Figure 02: Global Anti-microbial / Anti-fungal Tests Market Forecast & Y-o-Y Growth, 2022–2032
Figure 03: Global Anti-microbial / Anti-fungal Tests Market Absolute $ Opportunity (US$ Mn) Analysis, 2021–2032
Figure 04: Global Anti-microbial / Anti-fungal Tests Market Value Share (%) Analysis 2022 and 2032, by Test
Figure 05: Global Anti-microbial / Anti-fungal Tests Market Y-o-Y Growth (%) Analysis 2022-2032, by Test
Figure 06: Global Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis 2022–2032, by Test
Figure 07: Global Anti-microbial / Anti-fungal Tests Market Value Share (%) Analysis 2022 and 2032, by Infection
Figure 08: Global Anti-microbial / Anti-fungal Tests Market Y-o-Y Growth (%) Analysis 2022-2032, by Infection
Figure 09: Global Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis 2022–2032, by Infection
Figure 10: Global Anti-microbial / Anti-fungal Tests Market Value Share (%) Analysis 2022 and 2032, by End User
Figure 11: Global Anti-microbial / Anti-fungal Tests Market Y-o-Y Growth (%) Analysis 2022-2032, by End User
Figure 12: Global Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis 2022–2032, by End User
Figure 13: Global Anti-microbial / Anti-fungal Tests Market Value Share (%) Analysis 2022 and 2032, by Region
Figure 14: Global Anti-microbial / Anti-fungal Tests Market Y-o-Y Growth (%) Analysis 2022-2032, by Region
Figure 15: Global Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis 2022–2032, by Region
Figure 16: North America Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis, 2012–2021
Figure 17: North America Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Forecast, 2022-2032
Figure 18: North America Anti-microbial / Anti-fungal Tests Market Value Share, by Test (2022 E)
Figure 19: North America Anti-microbial / Anti-fungal Tests Market Value Share, by Infection (2022 E)
Figure 20: North America Anti-microbial / Anti-fungal Tests Market Value Share, by End User (2022 E)
Figure 21: North America Anti-microbial / Anti-fungal Tests Market Value Share, by Country (2022 E)
Figure 22: North America Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Test, 2022–2032
Figure 23: North America Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Infection, 2022–2032
Figure 24: North America Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by End User, 2022–2032
Figure 25: North America Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Country, 2022–2032
Figure 26: U.S. Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021
Figure 27: Global Vs. U.S. Growth Comparison, 2021-2032
Figure 28: U.S. Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032
Figure 29: U.S. Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032
Figure 30: U.S. Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032
Figure 31: Canada Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021
Figure 32: Global Vs. Canada. Growth Comparison, 2021-2032
Figure 33: Canada Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032
Figure 34: Canada Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032
Figure 35: Canada Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032
Figure 36: Latin America Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis, 2012–2021
Figure 37: Latin America Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Forecast, 2022-2032
Figure 38: Latin America Anti-microbial / Anti-fungal Tests Market Value Share, by Test (2022 E)
Figure 39: Latin America Anti-microbial / Anti-fungal Tests Market Value Share, by Infection (2022 E)
Figure 40: Latin America Anti-microbial / Anti-fungal Tests Market Value Share, by End User (2022 E)
Figure 41: Latin America Anti-microbial / Anti-fungal Tests Market Value Share, by Country (2022 E)
Figure 42: Latin America Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Test, 2022–2032
Figure 43: Latin America Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Infection, 2022–2032
Figure 44: Latin America Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by End User, 2022–2032
Figure 45: Latin America Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Country, 2022–2032
Figure 46: Mexico Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021
Figure 47: Global Vs Mexico Growth Comparison, 2021-2032
Figure 48: Mexico Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032
Figure 49: Mexico Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032
Figure 50: Mexico Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032
Figure 51: Brazil Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021
Figure 52: Global Vs. Brazil. Growth Comparison, 2021-2032
Figure 53: Brazil Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032
Figure 54: Brazil Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032
Figure 55: Brazil Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032
Figure 56: Argentina Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021
Figure 57: Global Vs Argentina Growth Comparison, 2021-2032
Figure 58: Argentina Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032
Figure 59: Argentina Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032
Figure 60: Argentina Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032
Figure 61: Europe Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis, 2012–2021
Figure 62: Europe Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Forecast, 2022-2032
Figure 63: Europe Anti-microbial / Anti-fungal Tests Market Value Share, by Test (2022 E)
Figure 64: Europe Anti-microbial / Anti-fungal Tests Market Value Share, by Infection (2022 E)
Figure 65: Europe Anti-microbial / Anti-fungal Tests Market Value Share, by End User (2022 E)
Figure 66: Europe Anti-microbial / Anti-fungal Tests Market Value Share, by Country (2022 E)
Figure 67: Europe Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Test, 2022–2032
Figure 68: Europe Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Infection, 2022–2032
Figure 69: Europe Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by End User, 2022–2032
Figure 70: Europe Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Country, 2022–2032
Figure 71: UK Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021
Figure 72: Global Vs. UK Growth Comparison, 2021-2032
Figure 73: UK Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032
Figure 74: UK Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032
Figure 75: UK Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032
Figure 76: Germany Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021
Figure 77: Global Vs. Germany Growth Comparison, 2021-2032
Figure 78: Germany Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032
Figure 79: Germany Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032
Figure 80: Germany Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032
Figure 81: Italy Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021
Figure 82: Global Vs. Italy Growth Comparison, 2021-2032
Figure 83: Italy Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032
Figure 84: Italy Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032
Figure 85: Italy Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032
Figure 86: France Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021
Figure 87: Global Vs France Growth Comparison, 2021-2032
Figure 88: France Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032
Figure 89: France Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032
Figure 90: France Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032
Figure 91: Spain Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021
Figure 92: Global Vs Spain Growth Comparison, 2021-2032
Figure 93: Spain Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032
Figure 94: Spain Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032
Figure 95: Spain Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032
Figure 96: Russia Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021
Figure 97: Global Vs Russia Growth Comparison, 2021-2032
Figure 98: Russia Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032
Figure 99: Russia Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032
Figure 100: Russia Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032
Figure 101: BENELUX Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021
Figure 102: Global Vs BENELUX Growth Comparison, 2021-2032
Figure 103: BENELUX Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032
Figure 104: BENELUX Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032
Figure 105: BENELUX Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032
Figure 106: East Asia Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis, 2012–2021
Figure 107: East Asia Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Forecast, 2022-2032
Figure 108: East Asia Anti-microbial / Anti-fungal Tests Market Value Share, by Test (2022 E)
Figure 109: East Asia Anti-microbial / Anti-fungal Tests Market Value Share, by Infection (2022 E)
Figure 110: East Asia Anti-microbial / Anti-fungal Tests Market Value Share, by End User (2022 E)
Figure 111: East Asia Anti-microbial / Anti-fungal Tests Market Value Share, by Country (2022 E)
Figure 112: East Asia Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Test, 2022–2032
Figure 113: East Asia Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Infection, 2022–2032
Figure 114: East Asia Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by End User, 2022–2032
Figure 115: East Asia Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Country, 2022–2032
Figure 116: China Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021
Figure 117: Global Vs. China Growth Comparison, 2021-2032
Figure 118: China Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032
Figure 119: China Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032
Figure 120: China Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032
Figure 121: Japan Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021
Figure 122: Global Vs. Japan Growth Comparison, 2021-2032
Figure 123: Japan Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032
Figure 124: Japan Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032
Figure 125: Japan Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032
Figure 126: South Korea Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021
Figure 127: Global Vs South Korea Growth Comparison, 2021-2032
Figure 128: South Korea Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032
Figure 129: South Korea Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032
Figure 130: South Korea Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032
Figure 131: South Asia Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis, 2012–2021
Figure 132: South Asia Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Forecast, 2022-2032
Figure 133: South Asia Anti-microbial / Anti-fungal Tests Market Value Share, by Test (2022 E)
Figure 134: South Asia Anti-microbial / Anti-fungal Tests Market Value Share, by Infection (2022 E)
Figure 135: South Asia Anti-microbial / Anti-fungal Tests Market Value Share, by End User (2022 E)
Figure 136: South Asia Anti-microbial / Anti-fungal Tests Market Value Share, by Country (2022 E)
Figure 137: South Asia Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Test, 2022–2032
Figure 138: South Asia Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Infection, 2022–2032
Figure 139: South Asia Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by End User, 2022–2032
Figure 140: South Asia Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Country, 2022–2032
Figure 141: India Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021
Figure 142: Global Vs. India Growth Comparison, 2021-2032
Figure 143: India Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032
Figure 144: India Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032
Figure 145: India Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032
Figure 146: Indonesia Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021
Figure 147: Global Vs. Indonesia Growth Comparison, 2021-2032
Figure 148: Indonesia Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032
Figure 149: Indonesia Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032
Figure 150: Indonesia Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032
Figure 151: Malaysia Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021
Figure 152: Global Vs. Malaysia Growth Comparison, 2021-2032
Figure 153: Malaysia Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032
Figure 154: Malaysia Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032
Figure 155: Malaysia Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032
Figure 156: Thailand Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021
Figure 157: Global Vs. Thailand Growth Comparison, 2021-2032
Figure 158: Thailand Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032
Figure 159: Thailand Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032
Figure 160: Thailand Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032
Figure 161: Oceania Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis, 2012–2021
Figure 162: Oceania Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Forecast, 2022-2032
Figure 163: Oceania Anti-microbial / Anti-fungal Tests Market Value Share, by Test (2022 E)
Figure 164: Oceania Anti-microbial / Anti-fungal Tests Market Value Share, by Infection (2022 E)
Figure 165: Oceania Anti-microbial / Anti-fungal Tests Market Value Share, by End User (2022 E)
Figure 166: Oceania Anti-microbial / Anti-fungal Tests Market Value Share, by Country (2022 E)
Figure 167: Oceania Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Test, 2022–2032
Figure 168: Oceania Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Infection, 2022–2032
Figure 169: Oceania Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by End User, 2022–2032
Figure 170: Oceania Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Country, 2022–2032
Figure 171: Australia Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021
Figure 172: Global Vs. Australia Growth Comparison, 2021-2032
Figure 173: Australia Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032
Figure 174: Australia Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032
Figure 175: Australia Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032
Figure 176: New Zealand Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021
Figure 177: Global Vs New Zealand Growth Comparison, 2021-2032
Figure 178: New Zealand Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032
Figure 179: New Zealand Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032
Figure 180: New Zealand Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032
Figure 181: Middle East & Africa Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis, 2012–2021
Figure 182: Middle East & Africa Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Forecast, 2022-2032
Figure 183: Middle East & Africa Anti-microbial / Anti-fungal Tests Market Value Share, by Test (2022 E)
Figure 184: Middle East & Africa Anti-microbial / Anti-fungal Tests Market Value Share, by Infection (2022 E)
Figure 185: Middle East & Africa Anti-microbial / Anti-fungal Tests Market Value Share, by End User (2022 E)
Figure 186: Middle East & Africa Anti-microbial / Anti-fungal Tests Market Value Share, by Country (2022 E)
Figure 187: Middle East & Africa Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Test, 2022–2032
Figure 188: Middle East & Africa Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Infection, 2022–2032
Figure 189: Middle East & Africa Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by End User, 2022–2032
Figure 190: Middle East & Africa Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Country, 2022–2032
Figure 191: GCC Countries Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021
Figure 192: Global Vs GCC Countries Growth Comparison, 2021-2032
Figure 193: GCC Countries Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032
Figure 194: GCC Countries Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032
Figure 195: GCC Countries Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032
Figure 196: Turkey Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021
Figure 197: Global Vs. Turkey Growth Comparison, 2021-2032
Figure 198: Turkey Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032
Figure 199: Turkey Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032
Figure 200: Turkey Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032
Figure 201: South Africa Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021
Figure 202: Global Vs. South Africa Growth Comparison, 2021-2032
Figure 203: South Africa Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032
Figure 204: South Africa Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032
Figure 205: South Africa Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032
Figure 206: North Africa Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021
Figure 207: Global Vs North Africa Growth Comparison, 2021-2032
Figure 208: North Africa Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032
Figure 209: North Africa Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032
Figure 210: North Africa Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
